GeneDx Holdings Corp.

Healthcare · Diagnostics & Research

71.50$ -6.2% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

GeneDx Holdings Corp. (WGS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 481 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet WGS
Line item	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	252	220	176	603	554	518	933	829	545	545	476	417	419	395	389	409	419	446	464	494	570	506	481
Current Assets	–	174	141	99	539	484	410	403	307	213	272	213	172	182	163	162	186	198	226	205	238	268	271	246
Cash	–	108	59	27	461	401	315	285	191	137	214	157	87	100	84	56	58	85	100	74	96	105	94	60
Cash & Short-Term Investments	–	108	59	27	461	401	315	285	191	137	214	157	114	130	113	107	116	141	159	135	155	171	171	133
Receivables	–	32	34	25	22	27	38	47	44	43	34	34	32	33	29	26	38	38	46	48	61	74	77	84
Inventory	–	25	33	29	31	33	36	42	44	14	12	12	9.3	8.8	12	10	11	11	13	12	11	14	12	18
Property, Plant & Equipment	–	–	–	–	–	–	–	–	128	84	–	77	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	181	181	–	–	–	–	–	–	–	–	0.0	–	13	13	14	1.6	1.6
Intangible Assets	–	–	–	–	–	–	–	194	190	187	183	180	176	173	169	166	162	159	155	177	173	168	145	141
Total Liabilities	–	247	406	406	212	166	188	296	268	292	217	180	163	191	187	195	204	174	189	187	202	262	252	237
Current Liabilities	–	73	68	71	71	101	101	205	162	144	119	84	68	59	51	68	77	55	70	71	88	109	88	75
Short-Term Debt	–	3.5	–	3.5	1.4	3.4	5.1	4.8	5.0	11	5.2	5.3	3.9	4.1	8.9	4.0	3.7	3.3	3.1	3.1	4.4	8.9	5.1	5.7
Accounts Payable	–	27	42	44	43	45	69	51	38	46	37	25	15	10	9.5	8.1	9.0	8.0	16	3.5	2.6	2.5	11	5.1
Long-Term Debt	–	–	–	–	–	11	11	11	11	6.3	6.3	6.3	6.1	53	52	52	52	52	52	52	52	48	97	97
Shareholders' Equity	–	4.4	-187	-230	391	388	329	637	561	254	328	296	254	228	207	194	205	245	257	277	292	308	254	244
Retained Earnings	–	-330	-521	-566	-535	-575	-652	-738	-816	-1,124	-1,185	-1,232	-1,274	-1,300	-1,320	-1,350	-1,358	-1,352	-1,359	-1,348	-1,356	-1,373	-1,437	-1,455
Shares Outstanding	5.6	5.6	5.6	5.6	6.4	7.3	7.4	10	12	12	20	25	26	26	26	27	27	27	28	30	29	27	29	30

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings